JFS Wealth Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

JFS Wealth Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262	Buy	+7	New	+$260	﹤0.01%	2094

Other funds holding CRNX

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LAM

Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

JFS Wealth Advisors's CRNX Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 7 shares worth $262. The stake represents ﹤0.01% of the portfolio and ranks #2094 among its holdings.

43 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

JFS Wealth Advisors held 7 shares of Crinetics Pharmaceuticals worth $262 as of Q2 2026.
Crinetics Pharmaceuticals was a new JFS Wealth Advisors position in Q2 2026.
Crinetics Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2094 holding.
43 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.